ImportRefusal LogoImportRefusal

CARE PHARMACEUTICALS

⚠️ Moderate Risk

FEI: 3013387843 • Amersfoort, Utrecht • NETHERLANDS

FEI

FEI Number

3013387843

📍

Location

Amersfoort, Utrecht

🇳🇱
🏢

Address

Stadsring 157A, , Amersfoort, Utrecht, Netherlands

Moderate Risk

FDA Import Risk Assessment

38.4
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

5
Total Refusals
4
Unique Violations
2/4/2019
Latest Refusal
8/22/2017
Earliest Refusal

Score Breakdown

Violation Severity
65.8×40%
Refusal Volume
28.8×30%
Recency
0.0×20%
Frequency
34.4×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

755×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1183×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

32803×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

4821×

NUTRIT LBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.

Refusal History

DateProductViolationsDivision
2/4/2019
66YBY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/30/2017
62GBY99ANTI-INFLAMMATORY N.E.C.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/16/2017
62GBY99ANTI-INFLAMMATORY N.E.C.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/22/2017
54YYE99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
482NUTRIT LBL
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/22/2017
62GBY99ANTI-INFLAMMATORY N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is CARE PHARMACEUTICALS's FDA import refusal history?

CARE PHARMACEUTICALS (FEI: 3013387843) has 5 FDA import refusal record(s) in our database, spanning from 8/22/2017 to 2/4/2019.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. CARE PHARMACEUTICALS's FEI number is 3013387843.

What types of violations has CARE PHARMACEUTICALS received?

CARE PHARMACEUTICALS has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about CARE PHARMACEUTICALS come from?

All FDA import refusal data for CARE PHARMACEUTICALS is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.